Robert L. Dobbins

10.1k total citations · 3 hit papers
60 papers, 8.0k citations indexed

About

Robert L. Dobbins is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Physiology. According to data from OpenAlex, Robert L. Dobbins has authored 60 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Surgery and 16 papers in Physiology. Recurrent topics in Robert L. Dobbins's work include Diabetes Treatment and Management (22 papers), Diabetes Management and Research (15 papers) and Pancreatic function and diabetes (15 papers). Robert L. Dobbins is often cited by papers focused on Diabetes Treatment and Management (22 papers), Diabetes Management and Research (15 papers) and Pancreatic function and diabetes (15 papers). Robert L. Dobbins collaborates with scholars based in United States, United Kingdom and Netherlands. Robert L. Dobbins's co-authors include Lidia S. Szczepaniak, Helen H. Hobbs, Jeffrey D. Browning, Scott M. Grundy, Julie McGarry, Jay D. Horton, Jonathan C. Cohen, Pamela Nurenberg, David Léonard and Jason Reingold and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Gastroenterology.

In The Last Decade

Robert L. Dobbins

58 papers receiving 7.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity

2004 2.9k citations Lidia S. Szczepaniak, Robert L. Dobbins et al. profile →
Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

2004 1.2k citations Lidia S. Szczepaniak, Robert L. Dobbins et al. profile →
Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo

1999 583 citations Lidia S. Szczepaniak, Robert L. Dobbins et al. profile →

Peers

Robert L. Dobbins

EPIDE

EDM

PHYSI

SURGE

Lidia S. Szczepaniak United States

Gianluca Perseghin Italy

Jeffrey D. Browning United States

Jukka Westerbacka Finland

Antti Hakkarainen Finland

Aynur Ünalp–Arida United States

Nina Lundbom Finland

Anna Kotronen Finland

Jamal A. Ibdah United States

Stergios Kechagias Sweden

Lidia S. Szczepaniak United States

Robert L. Dobbins

4.8k ×1.1

EPIDE

2.6k ×0.8

EDM

1.5k ×0.9

2.0k ×1.1

PHYSI

1.2k ×0.7

SURGE

Citations per year, relative to Robert L. Dobbins Robert L. Dobbins (= 1×) peers Lidia S. Szczepaniak

Countries citing papers authored by Robert L. Dobbins

Since Specialization

Citations

This map shows the geographic impact of Robert L. Dobbins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert L. Dobbins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert L. Dobbins more than expected).

Fields of papers citing papers by Robert L. Dobbins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert L. Dobbins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert L. Dobbins. The network helps show where Robert L. Dobbins may publish in the future.

Co-authorship network of co-authors of Robert L. Dobbins

This figure shows the co-authorship network connecting the top 25 collaborators of Robert L. Dobbins. A scholar is included among the top collaborators of Robert L. Dobbins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert L. Dobbins. Robert L. Dobbins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shiwach, Rajinder, Bernard Le Foll, Hannu Alho, et al.. (2025). Rapid vs Standard Induction to Injectable Extended-Release Buprenorphine. JAMA Network Open. 8(10). e2537319–e2537319. 2 indexed citations

Shiwach, Rajinder, Bernard Le Foll, Hannu Alho, et al.. (2025). Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use. JAMA Network Open. 8(12). e2548043–e2548043.

Laffont, Céline M., et al.. (2024). A Single‐Dose Study to Evaluate the Relative Bioavailability, Safety, and Tolerability of Monthly Extended-Release Buprenorphine at Alternative Injection Locations in Adult Participants with Opioid Use Disorder. Clinical Drug Investigation. 44(12). 939–949. 3 indexed citations

Mariani, John J., et al.. (2023). Open‐label investigation of rapid initiation of extended‐release buprenorphine in patients using fentanyl and fentanyl analogs. American Journal on Addictions. 33(1). 8–14. 8 indexed citations

Dobbins, Robert L., Amy Heath, Monique van Velzen, et al.. (2022). Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients. PLoS ONE. 17(1). e0256752–e0256752. 25 indexed citations

Olofsen, Erik, Robert L. Dobbins, Geert Jan Groeneveld, et al.. (2022). Modeling buprenorphine reduction of fentanyl-induced respiratory depression. JCI Insight. 7(9). 21 indexed citations

Olofsen, Erik, Robert L. Dobbins, Marieke Niesters, et al.. (2020). Tolerance to Opioid‐Induced Respiratory Depression in Chronic High‐Dose Opioid Users: A Model‐Based Comparison With Opioid‐Naïve Individuals. Clinical Pharmacology & Therapeutics. 109(3). 637–645. 39 indexed citations

Hegade, Vinod S., Stuart Kendrick, Robert L. Dobbins, et al.. (2017). Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study. The Lancet. 389(10074). 1114–1123. 162 indexed citations

Hegade, Vinod S., Stuart Kendrick, Robert L. Dobbins, et al.. (2016). BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial. BMC Gastroenterology. 16(1). 71–71. 33 indexed citations

10.

Sykes, A.P., et al.. (2014). Randomized efficacy and safety trial of once‐daily remogliflozin etabonate for the treatment of type 2 diabetes. Diabetes Obesity and Metabolism. 17(1). 98–101. 28 indexed citations

11.

Bush, Mark, Jessica Matthews, Erika H. De Boever, et al.. (2009). Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long‐acting glucagon‐like peptide‐1 mimetic, in healthy subjects. Diabetes Obesity and Metabolism. 11(5). 498–505. 143 indexed citations

12.

Zuo, Chun S., Rosemond A. Villafuerte, Michael Henry, et al.. (2006). Proton and sodium MRI assessment of fluid level in calf tissue. Journal of Magnetic Resonance Imaging. 24(1). 191–196. 3 indexed citations

13.

Szczepaniak, Lidia S., Robert L. Dobbins, Gregory J. Metzger, et al.. (2003). Myocardial triglycerides and systolic function in humans: In vivo evaluation by localized proton spectroscopy and cardiac imaging. Magnetic Resonance in Medicine. 49(3). 417–423. 349 indexed citations

14.

Majdič, Gregor, Morag J. Young, Elise P. Gómez-Sánchez, et al.. (2002). Knockout Mice Lacking Steroidogenic Factor 1 Are a Novel Genetic Model of Hypothalamic Obesity. Endocrinology. 143(2). 607–614. 228 indexed citations

15.

Szczepaniak, Lidia S., Robert L. Dobbins, Daniel T. Stein, & Julie McGarry. (2002). Bulk magnetic susceptibility effects on the assessment of intra‐ and extramyocellular lipids in vivo. Magnetic Resonance in Medicine. 47(3). 607–610. 63 indexed citations

16.

McGarry, Julie & Robert L. Dobbins. (1999). Fatty acids, lipotoxicity and insulin secretion. Diabetologia. 42(2). 128–138. 445 indexed citations

17.

Dobbins, Robert L., Stephen N. Davis, Doss W. Neal, et al.. (1998). Rates of glucagon activation and deactivation of hepatic glucose production in conscious dogs. Metabolism. 47(2). 135–142. 11 indexed citations

18.

Dobbins, Robert L., et al.. (1998). A fatty acid- dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion.. Journal of Clinical Investigation. 101(11). 2370–2376. 123 indexed citations

19.

Dobbins, Robert L., et al.. (1996). Counterregulation by epinephrine and glucagon during insulin-induced hypoglycemia in the conscious dog. Diabetes Research and Clinical Practice. 31(1-3). 45–56. 11 indexed citations

20.

Davis, Stephen N., Robert L. Dobbins, Stephen E. Nadeau, et al.. (1995). Evidence that the brain of the conscious dog is insulin sensitive.. Journal of Clinical Investigation. 95(2). 593–602. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact